MORbidity PRevalence Estimate In StrokE

Summary

Information regarding the likely progress of post-stroke symptoms is vitally important to stroke survivors to allow them to plan for the future and to adjust to life after stroke. Moreover, the prevalence of morbidity secondary to stroke is of central importance to Health Professionals to understand the prognosis of the disease in the patients under their care. Additionally, it will also allow commissioners of care, planners and third sector organisations to adapt to and answer the needs of a post-stroke population.

Currently, the data collected by national audit programmes are concentrated on what can be termed 'process or process of care' data. The utility of these data are in the ability to audit the care received by stroke survivors on stroke units against evidenced standards for care, thus ensuring evidence based practice. Nevertheless, process of care is only one form of measuring stroke unit care and the audit programmes collect some limited functional status data, data relating to risk-factor co-morbidities and treatment received data. Therefore, the scope of this study is to build on the minimum data set currently collected and to collect post-stroke data in domains not currently collected.

The International Consortium for Health Outcomes Measurement (ICHOM) takes important steps to collect data outside of process of care data such as a Patient Reported outcome data in their minimum outcome data set for stroke \[currently under review\].. Nevertheless, the ICHOM doesn't currently advocate the specific collection of data relating to cognitive impairment or emotional problems secondary to stroke. It is in these important aspects that this study will augment the data set currently advocated by ICHOM to collect data in the areas of cognitive impairment and emotional problems secondary to stroke.

Therefore, the aim of this study is to quantify the prevalence of morbidity at six months post-stroke.

Conditions

• Stroke
• CVA (Cerebrovascular Accident)
• CVA; Sequelae
• Stroke, Ischemic
• Stroke Hemorrhagic
• Hemianopia
• Hemiplegia
• Hemiparesis
• Aphasia
• Cerebral Infarction
• Intracerebral Hemorrhage
• Anxiety
• Depression
• Dysphagia
• Dysarthria
• Hemispatial Neglect
• Mild Cognitive Impairment

Sponsors & Collaborators

• Aneurin Bevan University Health Board

  lead OTHER

Principal Investigators

• Jonathan Hewitt, MBBS, PhD · Cardiff University & Aneurin Bevan University Health Board

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2018-09-30

Primary Completion

2019-08-31

Completion

2019-09-30

Countries

• United Kingdom

Study Locations